Hepatitis B Virus Reactivation in Asian Patients Treated With Rituximab-containing Treatment.
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 24 Jul 2015
At a glance
- Drugs Rituximab (Primary) ; Cyclophosphamide; Doxorubicin; Prednisone; Vincristine
- Indications Diffuse large B cell lymphoma; Follicular lymphoma
- Focus Adverse reactions
- 14 Jan 2013 Planned end date changed from 1 Dec 2012 to 1 Dec 2013 as reported by ClinicalTrials.gov.
- 14 Jan 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 23 May 2012 Planned End Date changed from 1 Aug 2011 to 1 Dec 2012 as reported by ClinicalTrials.gov.